Trial Profile
A Compassionate Use Trial With Bicalutamide (CASODEX) 150-mg for Subjects With Prostate Cancer
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 22 Apr 2008
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 22 Apr 2008 Status change
- 16 Apr 2008 New trial record.